FindTrial
Sign In

Understanding How Panchakarma Detox Therapy Affects Body Cells in Healthy Adults

An open-label, randomized, exploratory study to evaluate the effect of Shodhananga Snehapan Followed by Virechana on Membrane Lipidomics and Fluidity in Human Cells of Healthy Individuals. - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/104813
Enrollment
40
Registered
2026-02-25
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

All India Institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Subjects who are willing to sign the informed written consent. 2.Subjects of age group 18 years - 40 years irrespective of their gender, caste, or religion. 3.Snehapana arha and Virechana arha ( Subjects fit for snehana and virechana) 4.Subjects who are currently not participating in any other clinical trial or are not registered in any other research study in last 12 weeks. 5.Apparently healthy volunteers without any illness and not on any medications in the past 3 months.

Exclusion criteria

Exclusion criteria: 1.Pregnant women and lactating mothers. 2. Subjects having comorbodities like Hypertension, Diabetes Mellitus, Thyroid disorder, erythrocyte disorders including anaemia, sickle cell disease, hereditary membranopathies leading to altered shape, stability and function of RBCs or any other systemic illness or condition that may jeopardize the study. 3.Subjects having history of prolonged medication with corticosteroids, diuretics, anti-dyslipidaemic drugs etc or any other drugs that may influence the outcome of the study.

Design outcomes

Primary

MeasureTime frame
Change in cell membrane lipidomics and membrane fluidity of human RBCs of healthy individuals. Timepoint: To asses Membrane lipidomics and Membrane fluidity, investigations will be done at following intervals: In Interventional Group (n=30):- Baseline (BT) 0th Day After Completion of Snehana (AT1) After Completion of Svedana (AT2)-(only for n=10 subjects) After Completion of Samsarjana Krama (AT3) In Control Group (n=10):- Baseline 0th Day and On 23rd day—

Secondary

MeasureTime frame
1.Improvement in quality of life (assesed by using WHOQOL-BREF scale). 2.Change in Plasma Metabolome.Timepoint: In Interventional group, Improvement in quality of life (for n=30 subjects),Change in plasma metabolome( for n = 15 subjects) assessed in following intervals:- Baseline (BT) 0th day After Completion of Samsarjan Krama In Control Group (n=10):- Baseline 0th Day and On 23rd day—

Countries

India

Contacts

Public ContactProf Dr Anandaraman P V

All India Institute of Ayurveda, New Delhi

dr.ananthramsharma@gmail.com9495130595

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026